Ginkgo Bioworks downgraded by Raymond James with a new price target
$DNA
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Raymond James downgraded Ginkgo Bioworks from Outperform to Mkt Perform and set a new price target of $2.50 from $3.50 previously